National Bank of Canada
ABMD

National Bank of Canada’s Abiomed Inc ABMD Stock Holding History

National Bank of Canada’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-161
Closed -$40K – 2965
2022
Q3 		$40K Hold
161
– – ﹤0.01% 1774
2022
Q2 		$40K Sell
161
-6
-4% -$1.62K ﹤0.01% 1831
2022
Q1 		$55K Sell
167
-2,804
-94% -$863K ﹤0.01% 1848
2021
Q4 		$1.07M Buy
+2,971
New +$1M ﹤0.01% 1029

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

National Bank of Canada's ABMD Position: Q4 2022 in Review

National Bank of Canada sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 161 shares — an estimated $40K sold.

National Bank of Canada first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $1.07M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • National Bank of Canada reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • National Bank of Canada sold 161 Abiomed Inc shares in Q4 2022, an estimated $40K.
  • National Bank of Canada first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
  • National Bank of Canada's Abiomed Inc position peaked at $1.07M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on National Bank of Canada's 13F filing for Q4 2022, filed 24 Jan 2023.